Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about TEVA PHARMACEUTICAL INDUST
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Kiryat Shmona braces for Teva plant closure
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Yitzhak Peterburg steps down
12/13 TEVA PHARMACEUTICAL INDUSTRIES : to fire at least 3,000 in Israel
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 TEVA TO HOST CONFERENCE CALL TO DISC : 00 a.m. ET on December 14, 2017
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra Ta..
12/11 EXCLUSIVE : Teva to fire 500 managers in Israel
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
12/10 TEVA PHARMACEUTICAL INDUSTRIES : mulls 10,000 layoffs - report
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08DJTEVA PHARMACEUTICAL INDUSTRIES : May Cut Up to 10,000 Jobs -Bloomberg
11/30 TEVA PHARMACEUTICAL INDUSTRIES LTD : . - The New England Journal of Medicine Pub..
11/29DJNew Migraine Drugs Show Promise in Race to Sell Next-Generation Treatments
More most relevant news
All news about TEVA PHARMACEUTICAL INDUST
04:54a TEVA PHARMACEUTICAL INDUSTRIES : Histadrut calls strike over Teva cuts
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Kiryat Shmona braces for Teva plant closure
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Yitzhak Peterburg steps down
12/13 TEVA PHARMACEUTICAL INDUSTRIES : to fire at least 3,000 in Israel
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 TEVA TO HOST CONFERENCE CALL TO DISC : 00 a.m. ET on December 14, 2017
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra Ta..
12/11 EXCLUSIVE : Teva to fire 500 managers in Israel
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
More news
Sector news : Pharmaceuticals - NEC
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/13DJELI LILLY AND : Sees Modest Revenue Growth in 2018
12/13 SANOFI : CEO says M&A targets in oncology are 'very expensive'
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/13DJSANOFI : to Begin at Least 10 Phase 3 Studies Over Next 12 Months
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/13 Teva down 6% ahead of details on restructuring plan
12/13 WALL STREET BREAKFAST : Fed Decision, Outlook On Watch
12/13 Teva restructuring plan coming Thursday
12/12 Premarket analyst action - healthcare
12/11 FDA accepts Lilly's marketing application for migraine med galcanezumab
12/11 TEVA : Is This What A Bloodbath Looks Like?
Financials ($)
Sales 2017 22 633 M
EBIT 2017 6 276 M
Net income 2017 -
Debt 2017 34 419 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 2,23x
EV / Sales 2018 2,12x
Capitalization 15 987 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 24,5 $
Spread / Average Target 54%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-59.51%15 987
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.01%218 773
PFIZER10.04%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659